Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Ventricular Dysfunction, Left

• DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction
• Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines
• Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
• Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19
• Human Embryonic Stem Cell-Derived Cardiomyocyte Therapy for Chronic Ischemic Left Ventricular Dysfunction
• The Effect of Early Administration of Dapagliflozin in STEMI Patients With LV Systolic Dysfunction
• Landiolol for Rate Control in Decompensated Heart Failure Due to Atrial Fibrillation
• Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation
• Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction
• Sex Differences in Myocardial Steatosis Induced Left Ventricular Dysfunction
• Performance and Safety of the Cardiac Microcurrent Therapy System
• Compare the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy Versus Rosuvastatin Monotherapy in Korean Patients With Left Ventricular Diastolic Dysfunction and Hyperlipidemia
• Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion
• Ivabradine in Cirrhotic Cardiomyopathy
• Firibastat or Ramipril After Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction
• The Effects of Sacubitril/Valsartan Compared to Valsartan on LV Remodelling in Asymptomatic LV Systolic Dysfunction After MI
• Urate Lowering Therapies and Left Ventricular Diastolic Dysfunction
• A Study of Ivabradine in African-American/ Black Subjects With Heart Failure and Left Ventricular Systolic Dysfunction.
• A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY 1142524 in Patients After Acute Myocardial Infarction With Left-ventricular Dysfunction
• Preoperative levosimendán and Hip Fracture
• Safety of Continuing CHemotherapy in Overt Left Ventricular Dysfunction Using Antibodies to HER-2
• Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry
• Pharmacological Reduction of Functional, Ischemic Mitral REgurgitation
• Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation
• Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMAN
• NP202 for Treatment of Post -STEMI Left Ventricular Systolic Dysfunction
• High-dose Selenium Supplementation in Patients With Left Ventricular Assist
• The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial.
• A Single-blind Pilot Study to Investigate Safety and Tolerability of the Chymase Inhibitor BAY1142524 in Clinically Stable Patients With Left-ventricular Dysfunction
• Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction With Type 2 Diabetes Mellitus Study
• Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome
• Study of Ranolazine in the Treatment of Pulmonary Hypertension Associated With Diastolic Left Ventricular Dysfunction
• Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
• Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass
• The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation
• STem cElls Mobilization in Acute Myocardial Infarction Outcome Trial
• Effect of Nebivolol on the Blood Flow in Hearts of Adults With High Blood Pressure and Abnormal Filling of Heart
• Confirmatory Study of IK-3001 in Japanese Subjects With Peri-/Post-op Pulmonary Hypertension Assoc. With Cardiac Surgery
• Phase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Diseas
• Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView.
• Diastolic Dysfunction in Patients With Type 2 Diabetes Mellitus
• Heart Rate Response to Regadenoson and Sudden Cardiac Death
• Bi Treatment With Hydralazine/Nitrates Versus Placebo in Africans Admitted With Acute Heart Failure
• Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Chroni
• Characterization of LV Strain Patterns in Mildly Elevated PCWP and PAH.
• COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure
• Furosemide Treatment Before Blood Transfusion in Patients With Systolic Dysfunction
• Glucagon-like Peptide 1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Patients With Aortocoronary Bypass
• Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure (ATOMIC-AHF)
• Single Ascending Doses of GGF2 in Patients With Left Ventricular Dysfunction and Symptomatic Heart Failure
• A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Diastolic Dysfunction
• Prevention of Left Ventricular Dysfunction During Chemotherapy
• A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction
• Hemodynamic and Echocardiographic Assessment of Riociguat Effects on Myocardial Wall Contractility and Relaxation Kinetics
• Effect of Ranolazine on Arrhythmias and Microvolt T- Wave Alternans (MVTWA) Patients With LV Dysfunction
• Effects of Nebivolol on Subclinical Left Ventricular dySfunction: A Comparative Study Against Metoprolol
• The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633 AM1)(TERMINATED)
• Effects of Viagra on Heart Function in Patients With Heart Failure
• Investigate the Effect of AZD1305 on Patients With Left Ventricular Dysfunction
• Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function
• Human Brain Natriuretic Peptide (BNP) (or Nesiritide) to Help Heart, Kidney and Humoral Function.
• Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone
• Effects of Rosiglitazone on Plasma BNP Levels and Left Ventricular Dysfunction
• Drug Compliance and Quality of Life in Patients With Heart Failure Dosed With Either Once-daily or Twice-daily Coreg
• Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
• Insulin Cardioplegia for Poor Left Ventricular Function
• The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction
• Studies of Left Ventricular Dysfunction (SOLVD)